日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm

Pivekimab Sunirine 治疗浆细胞样树突状细胞肿瘤

Pemmaraju, Naveen; Marconi, Giovanni; Montesinos, Pau; Lane, Andrew A; Mazzarella, Luca; Sallman, David A; Ulrickson, Matthew L; Schiller, Gary J; Erba, Harry P; Wang, Eunice S; Walter, Roland B; Deconinck, Eric; Aribi, Ahmed; Legrand, Ollivier; Lebon, Delphine; Maisano, Valerio; Martinelli, Giovanni; DeAngelo, Daniel J; Derenzini, Enrico; Du, Yining; Lakshmikanthan, Sribalaji; Potluri, Jalaja; Kantarjian, Hagop M; Daver, Naval G

Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial"

更正:“在QuANTUM-First试验中,造血细胞移植和quizartinib对新诊断的伴有FMS样酪氨酸激酶3内部串联重复的急性髓系白血病患者的影响”

Schlenk, Richard F; Montesinos, Pau; Kim, Hee-Je; Romero-Aguilar, Antonio; Vrhovac, Radovan; Patkowska, Elżbieta; Žák, Pavel; Wang, Po-Nan; Hanyok, James; Liu, Li; Kamel, Yasser Mostafa; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Hervé; Amadori, Sergio; Wang, Jianxiang; Perl, Alexander E; Levis, Mark J; Erba, Harry P

FLT3-ITD measurable residual disease from the QuANTUM-First trial

Quantum-First试验中FLT3-ITD可测量残留病灶

Levis, Mark J; Erba, Harry P; Montesinos, Pau; Kim, Hee-Je; Vrhovac, Radovan; Patkowska, Elżbieta; Žák, Pavel; Wang, Po-Nan; Connolly Rohrbach, Jaime E; Chang, Ken C N; Liu, Li; Mostafa Kamel, Yasser; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Hervé; Amadori, Sergio; Wang, Jianxiang; Schlenk, Richard F; Perl, Alexander E

Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid Leukemia

基于全基因组测序的急性髓系白血病患者个性化可测量残留病灶检测

Ravindra, Niveditha; Lack, Justin; Dalgard, Clifton L; vanCollenburg, Eddy; Corner, Adam; Beppu, Lan; Erba, Harry; Othus, Megan; Radich, Jerald P; Dillon, Laura W; Hourigan, Christopher S

Ziftomenib in Relapsed or Refractory NPM1-Mutated AML

Ziftomenib治疗复发或难治性NPM1突变型急性髓系白血病

Wang, Eunice S; Montesinos, Pau; Foran, James; Erba, Harry; Rodríguez-Arbolí, Eduardo; Fedorov, Kateryna; Heiblig, Maël; Heidel, Florian H; Altman, Jessica K; Baer, Maria R; Ades, Lionel; Pettit, Kristen; Peterlin, Pierre; Papayannidis, Cristina; Berthon, Céline; Walter, Roland B; Shah, Mithun V; Balasubramanian, Suresh; Khawandanah, Mohamad; Salamero Garcia, Olga; Bergeron, Julie; Madanat, Yazan F; Roboz, Gail J; Ulrickson, Matthew; Redner, Robert L; McCloskey, James; Pigneux, Arnaud; de la Fuente Burguera, Adolfo; Mitra, Amitava; Soifer, Harris S; Tabachri, Marilyn; Zhang, Zijing; Riches, Marcie; Corum, Daniel; Leoni, Mollie; Issa, Ghayas C; Fathi, Amir T

Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203

7+3方案再诱导治疗与高剂量阿糖胞苷再诱导治疗的缓解概率:SWOG试验S1203分析

Othus, Megan; Garcia-Manero, Guillermo; Appelbaum, Frederick R; Erba, Harry P; Dietrich, Eliana; Raychaudhuri, Suravi; Appelbaum, Jacob; Estey, Elihu; Percival, Mary-Elizabeth

Biobanking and consent to future biospecimen use among adults enrolled in SWOG trials from 2000 to 2024

2000年至2024年参与SWOG试验的成年人的生物样本库建立及未来生物样本使用同意书

Olivieri, Daniel J; Berridge-Green, Alexis; Othus, Megan; Radich, Jerald P; Advani, Anjali S; Erba, Harry P; Walter, Roland B

Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition with Quizartinib and Milademetan in FLT3-ITD Mutant/TP53 Wild-type Acute Myeloid Leukemias

Quizartinib 和 Milademetan 联合抑制 FLT3-ITD 和 MDM2 对 FLT3-ITD 突变/TP53 野生型急性髓系白血病具有协同作用

Zhang, Weiguo; Li, Li; Muftuoglu, Muharrem; Basyal, Mahesh; Togashi, Noriko; Iwanaga, Koichi; Tanzawa, Fumie; Numata, Masashi; Bixby, Dale L; Erba, Harry P; Podoltsev, Nikolai; Schiller, Gary J; Kumar, Prasanna; Lesegretain, Arnaud; Isoyama, Takeshi; Seki, Takahiko; Daver, Naval; Andreeff, Michael

Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial

在QuANTUM-First试验中,造血干细胞移植和quizartinib对新诊断的伴有FMS样酪氨酸激酶3内部串联重复的急性髓系白血病患者的影响

Schlenk, Richard F; Montesinos, Pau; Kim, Hee-Je; Romero-Aguilar, Antonio; Vrhovac, Radovan; Patkowska, Elżbieta; Žak, Pavel; Wang, Po-Nan; Hanyok, James; Liu, Li; Kamel, Yasser Mostafa; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Herve; Amadori, Sergio; Wang, Jianxiang; Perl, Alexander E; Levis, Mark J; Erba, Harry P

Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912

E1912 研究中,接受伊布替尼治疗的 CLL 患者中,IGHV 突变状态与耐受性和长期疾病控制之间的关系

Shanafelt, Tait D; Wang, Xin Victoria; Hanson, Curtis A; Paietta, Elisabeth; O'Brien, Susan; Barrientos, Jacqueline; Jelinek, Diane F; Braggio, Esteban; Leis, Jose F; Zhang, Cong Christine; Barr, Paul M; Cashen, Amanda F; Mato, Anthony R; Singh, Avina K; Mullane, Michael P; Little, Richard F; Erba, Harry; Stone, Richard M; Litzow, Mark; Tallman, Martin; Kay, Neil E